DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
about
DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
description
scientific article published on 07 December 2018
@en
name
DOTA-MGS5, a New Cholecystokin ...... ng Profile for Theranostic Use
@en
type
label
DOTA-MGS5, a New Cholecystokin ...... ng Profile for Theranostic Use
@en
prefLabel
DOTA-MGS5, a New Cholecystokin ...... ng Profile for Theranostic Use
@en
P2093
P1476
DOTA-MGS5, a New Cholecystokin ...... ng Profile for Theranostic Use
@en
P2093
Christine Rangger
Dominik Summer
Irene Virgolini
Jane Sosabowski
Julie Foster
Maximilian Klingler
Roland Haubner
P304
P356
10.2967/JNUMED.118.221283
P407
P577
2018-12-07T00:00:00Z